What is the average price target for INVO FERTILITY INC (IVF) stock?
5 analysts have analysed IVF and the average price target is 20.4 USD. This implies a price increase of 871.43% is expected in the next year compared to the current price of 2.1.
INVO FERTILITY INC (IVF) Forecast, Price Target & Analyst Ratings
NASDAQ:IVF • US44984F8077
Current stock price
2.1 USD
-0.03 (-1.41%)
At close:
2.14 USD
+0.04 (+1.9%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for INVO FERTILITY INC (IVF).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Apr 28, 2026
- Period
- Q4 / 2025
- EPS Estimate
- -$2.78
- Revenue Estimate
- 1.946M
Price Target Details & History
Consensus Price Target and Range
Mean target
$20.40
Upside
+ 871.43%
From current price of $2.10 to mean target of $20.40, Based on 5 analyst forecasts
Low
$20.20
Median
$20.40
High
$21.00
Price Target Revisions
1 Month
400.00%
3 Months
-86.11%
Price Target Summary
5 Wall Street analysts provided a forecast for the next 12 months for IVF. The average price target is 20.4 USD. This implies a price increase of 871.43% is expected in the next year compared to the current price of 2.1.
The average price target has been revised downward by 86.11% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
80.00%
IVF was analyzed by 5 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about IVF.
In the previous month the buy percentage consensus was at a similar level.
Only 5 analysts analyzed IVF. So this is just the average opinion of a couple of analysts.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Apr 28, 2026
- Period
- Q4 / 2025
- EPS Estimate
- -$2.78
- Revenue Estimate
- 1.946M
- Revenue Q2Q
- -61.84%
- EPS Q2Q
- 99.91%
- Number of Analysts
- 2
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
2.21%
EPS (1 Month)
-400.00%
EPS (3 Months)
-5,400.00%
Next Earnings Summary
IVF is expected to report earnings on 4/28/2026. The consensus EPS estimate for the next earnings is -2.78 USD and the consensus revenue estimate is 1.95M USD.
The next earnings revenue estimate has been revised upward by 2.21% in the past 3 months.
Full Analyst Estimates 2025 - 2033
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 820K -80.29% | 3.021M 268.37% | 6.532M 116.25% | 7.257M 11.10% | 10.523M 45.00% | 16.626M 58.00% | 9.384M -43.56% | 39.403M 319.90% | 53.195M 35.00% | 63.833M 20.00% | 76.6M 20.00% | 91.92M 20.00% | |
| EBITDA YoY % growth | -10.55M -103.28% | -6.566M 37.76% | -6.694M -1.95% | -2.764M 58.70% | -2.3M 16.81% | 276.74K 112.03% | N/A | 10.191M | 15.184M 48.99% | 18.221M 20.00% | 23.235M 27.52% | 29.389M 26.49% | |
| EBIT YoY % growth | -10.63M -103.64% | -6.767M 36.34% | -7.614M -12.51% | -23.096M -203.34% | -4.645M 79.89% | -2.187M 52.92% | -56.585M -2,487.76% | 6.94M 112.26% | 11.283M 62.58% | 13.539M 19.99% | 18.085M 33.58% | 23.723M 31.18% | |
| Operating Margin | -1,296.34% | -224.03% | -116.56% | -318.25% | -44.14% | -13.15% | -603.00% | 17.61% | 21.21% | 21.21% | 23.61% | 25.81% | |
| EPS YoY % growth | -25,632.00 -32.44% | N/A 100.00% | N/A -464,900.00% | -150.04 92.01% | -2.93 98.05% | -1.01 65.52% | -5.06 -401.00% | 2.02 139.92% | 3.47 72.00% | 4.20 20.93% | 5.66 34.62% | 7.35 30.00% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -2.78 99.91% | -1.26 -73.61% | -0.71 -1,066.67% | -0.66 14.74% | -0.11 96.00% |
| Revenue Q2Q % growth | 1.946M -61.84% | 2M 22.16% | 2.42M 29.85% | 2.736M 55.45% | 3.367M 73.02% |
| EBITDA Q2Q % growth | -869.61K 65.82% | -870.62K 60.92% | -676.7K 43.06% | -507.02K 53.68% | -245.43K 71.78% |
| EBIT Q2Q % growth | -1.414M 59.18% | -1.41M 42.74% | -1.239M 22.19% | -1.117M 31.70% | -878.7K 37.86% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
25.98%
EPS Next 5 Year
14.88%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
37.40%
Revenue Next 5 Year
43.80%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
27.17%
EBIT Next 5 Year
32.46%
INVO FERTILITY INC / IVF Forecast FAQ
When does INVO FERTILITY INC (IVF) report earnings?
INVO FERTILITY INC (IVF) will report earnings on 2026-04-28, after the market close.
Can you provide the consensus estimates for INVO FERTILITY INC next earnings?
The consensus EPS estimate for the next earnings of INVO FERTILITY INC (IVF) is -2.78 USD and the consensus revenue estimate is 1.95M USD.
What is the expected long term growth rate for IVF stock?
The expected long term growth rate for INVO FERTILITY INC (IVF) is 37.4%.